Consolidated Balance Sheets - USD ($) $ in Millions	Oct. 31, 2025	Oct. 31, 2024
Current assets:
Cash, cash equivalents and restricted cash	$ 3,705	$ 3,253
Accounts receivable, net of allowance for credit losses of $83 as of October 31, 2025 and 2024	5,692	5,117
Inventory	8,512	7,720
Other current assets	4,544	4,670
Total current assets	22,453	20,760
Property, plant and equipment, net	3,049	2,914
Goodwill	8,706	8,627
Other non-current assets	7,561	7,608
Total assets	41,769	39,909
Current liabilities:
Notes payable and short-term borrowings	845	1,406
Accounts payable	18,051	16,903
Other current liabilities	10,362	10,378
Total current liabilities	29,258	28,687
Long-term debt	8,821	8,263
Other non-current liabilities	4,036	4,282
Commitments and contingencies
Stockholders’ deficit:
Preferred stock, $0.01 par value (300 shares authorized; none issued)	0	0
Common stock, $0.01par value (9,600 shares authorized; 921 and 939 shares issued and outstanding as of October 31, 2025 and 2024, respectively)	9	9
Additional paid-in capital	2,129	1,778
Accumulated deficit	(2,027)	(2,676)
Accumulated other comprehensive loss	(457)	(434)
Total stockholders’ deficit	(346)	(1,323)
Total liabilities and stockholders’ deficit	$ 41,769	$ 39,909